Země: Irsko
Jazyk: angličtina
Zdroj: HPRA (Health Products Regulatory Authority)
Midodrine hydrochloride
Morningside Healthcare (Malta) Limited
C01CA17
Midodrine hydrochloride
Tablet
midodrine
Not marketed
2022-09-16
1 PACKAGE LEAFLET: INFORMATION FOR THE USER MIDODRINE HYDROCHLORIDE MORNINGSIDE 2.5 AND 5 MG TABLETS MIDODRINE HYDROCHLORIDE READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor or pharmacist. • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET : 1. What Midodrine Hydrochloride Morningside 2.5 and 5 mg Tablets are and what are they used for 2. What you need to know before you take Midodrine Hydrochloride Morningside 2.5 and 5 mg Tablets 3. How to take Midodrine Hydrochloride Morningside 2.5 and 5 mg Tablets 4. Possible side effects 5. How to store Midodrine Hydrochloride Morningside 2.5 and 5 mg Tablets 6. Contents of the pack and other information 1. WHAT MIDODRINE HYDROCHLORIDE MORNINGSIDE 2.5 AND 5 MG TABLETS ARE AND WHAT ARE THEY USED FOR Midodrine Hydrochloride Morningside 2.5 and 5 mg Tablets contain the active ingredient midodrine hydorchloride, which acts on the blood vessels via the sypatheic nervous system to correct imbalances of blood distribution, such as preventing too much blood pooling in the legs when standing up. Midodrine Hydrochloride Morningside 2.5 and 5 mg Tablets are used to stop the fall in your blood pressure as a result of your sympathetic nervous system not working correctly. This should help to relieve the symptoms which you might be suffering such as dizziness, fainting, blurred vision and weakness when you sit or stand up. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE MIDODRINE HYDROCHLORIDE MORNINGSIDE 2.5 AND 5 MG TABLETS _ _ DO NOT TAKE MIDODRINE HYDROCHLORIDE MORNINGSIDE 2.5 AND 5 MG TABLETS IF YOU: • are allergic to midodrine hydroch Přečtěte si celý dokument
Health Products Regulatory Authority 16 September 2022 CRN00CDH2 Page 1 of 6 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Midodrine Hydrochloride Morningside 2.5 mg Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 2.5 mg of midodrine hydrochloride. For the full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM Tablet. White, round tablet, diameter approximately 7 mm with M2 debossed on one side and score line on the other side. The score-line is only to facilitate breaking for ease of swallowing and not to divide into equal doses. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS For use in adults for the treatment of severe orthostatic hypotension due to dysfunction of the autonomic nervous system when corrective factors have been ruled out. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology Adults: The usual starting dose is 2.5 mg 3 times daily. A dosing schedule of 3-4 hour intervals is suggested. The last dose should be taken at least four hours before bedtime to reduce the risk of supine hypertension. The dose should be increased at weekly intervals in small increments until an optimal response is obtained. Most patients are controlled at or below 30 mg daily given in 3 divided doses. The maximum daily dose is 30 mg given in 3 divided doses. Doses in excess of 30 mg daily are not recommended. The supine and standing blood pressure should be monitored regularly during initial treatment (at least two times a week) and the use of midodrine should be stopped if supine hypertension increases excessively. Dosing of midodrine should occur during the daytime, when the patient needs to be upright. Elderly: Although there is no evidence to suggest that dosage requirements are different in the elderly, it is recommended that the initial dose used be small and that increases in dosage be titrated against the patients clinical condition with caution. The administration of midodrine should be stopped and the attending physician notified immediately if the blood pressu Přečtěte si celý dokument